OGGIONI, NORBERTO
 Distribuzione geografica
Continente #
NA - Nord America 13.650
AS - Asia 8.400
EU - Europa 6.148
SA - Sud America 1.062
AF - Africa 198
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 22
Totale 29.524
Nazione #
US - Stati Uniti d'America 12.971
SG - Singapore 3.292
CN - Cina 1.813
DE - Germania 1.088
HK - Hong Kong 1.043
RU - Federazione Russa 943
VN - Vietnam 885
SE - Svezia 871
BR - Brasile 783
IT - Italia 711
IE - Irlanda 676
CA - Canada 571
UA - Ucraina 560
GB - Regno Unito 377
FR - Francia 292
IN - India 269
KR - Corea 186
FI - Finlandia 172
BD - Bangladesh 140
AT - Austria 117
ID - Indonesia 110
AR - Argentina 106
TR - Turchia 96
JP - Giappone 88
IQ - Iraq 76
DK - Danimarca 69
ZA - Sudafrica 69
MX - Messico 67
NL - Olanda 55
PK - Pakistan 53
ES - Italia 52
PL - Polonia 47
MY - Malesia 42
SA - Arabia Saudita 42
PH - Filippine 41
EC - Ecuador 35
CO - Colombia 34
VE - Venezuela 29
IR - Iran 27
CL - Cile 24
BE - Belgio 22
AU - Australia 21
MA - Marocco 21
EG - Egitto 20
PY - Paraguay 20
UZ - Uzbekistan 20
ET - Etiopia 19
NZ - Nuova Zelanda 19
EU - Europa 18
KZ - Kazakistan 18
KE - Kenya 17
LT - Lituania 17
AE - Emirati Arabi Uniti 16
JO - Giordania 16
NP - Nepal 16
TN - Tunisia 16
TH - Thailandia 15
CH - Svizzera 14
UY - Uruguay 14
AZ - Azerbaigian 12
OM - Oman 11
IL - Israele 10
CZ - Repubblica Ceca 9
PE - Perù 9
PS - Palestinian Territory 9
AL - Albania 7
BG - Bulgaria 7
BH - Bahrain 7
BO - Bolivia 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
AO - Angola 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
GE - Georgia 6
NG - Nigeria 6
PA - Panama 6
RS - Serbia 6
TW - Taiwan 6
DZ - Algeria 5
HR - Croazia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
HU - Ungheria 4
MD - Moldavia 4
RO - Romania 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GT - Guatemala 3
HN - Honduras 3
KW - Kuwait 3
MM - Myanmar 3
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CI - Costa d'Avorio 2
Totale 29.485
Città #
Singapore 2.065
Ann Arbor 1.879
Ashburn 1.005
Hong Kong 997
San Jose 916
Woodbridge 819
Chandler 706
Dublin 654
Jacksonville 550
Houston 535
Frankfurt am Main 489
Fairfield 456
Wilmington 448
Dearborn 424
Toronto 368
New York 349
Dallas 346
Beijing 271
Santa Clara 268
Milan 267
Ho Chi Minh City 249
Princeton 244
Los Angeles 240
Chicago 211
The Dalles 200
Hanoi 183
Seattle 181
Nanjing 178
Boardman 174
Council Bluffs 161
Cambridge 138
Shanghai 133
Seoul 131
Hefei 120
Vienna 111
Lauterbourg 110
Lachine 89
Buffalo 88
Dong Ket 78
Guangzhou 78
Jakarta 77
Moscow 75
Altamura 73
Lawrence 71
Orem 67
Nanchang 59
São Paulo 59
Munich 54
Helsinki 53
Fremont 45
Shenyang 44
Andover 42
Tokyo 41
Grafing 40
Jinan 40
Zhengzhou 37
Da Nang 36
Jiaxing 36
Johannesburg 34
Nürnberg 33
San Diego 33
Tianjin 32
Baghdad 31
Brooklyn 31
Changsha 31
Chennai 31
Montreal 31
Phoenix 31
Rio de Janeiro 30
London 29
Pune 29
Atlanta 28
Columbus 27
Denver 27
Falls Church 26
Ottawa 26
Haiphong 25
Daejeon 24
Hangzhou 24
Kunming 24
Ankara 23
Mountain View 23
Warsaw 23
Hebei 22
Nuremberg 22
Philadelphia 22
Basingstoke 21
Boston 21
Brussels 21
Istanbul 21
Dhaka 20
Rome 20
Sacramento 20
Tashkent 20
Addis Ababa 19
San Francisco 19
Stockholm 19
Turku 19
Lahore 17
Poplar 17
Totale 18.904
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 492
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 447
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 431
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 421
Age-related changes in the function and structure of the peripheral sensory pathway in mice 420
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 420
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 407
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 404
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 397
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 380
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 369
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 345
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 333
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 328
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 319
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 313
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 312
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 312
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 309
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 304
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 300
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 299
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 298
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 293
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 293
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 292
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 290
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 290
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 289
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 288
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 286
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 286
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 283
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 283
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 278
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 270
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 268
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 267
Effect of proteasome inhibition on the central and peripheral nervous system 265
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 263
Multimodal experimental approach to the study of human neurological diseases 263
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 262
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 257
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 253
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 252
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 249
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 248
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 247
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 246
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 246
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 245
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 245
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 244
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 243
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 243
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 242
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 241
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 241
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 241
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 240
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 240
Lipoplatin tm: a less neurotoxic formulation of cisplatin 236
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 236
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 234
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 234
Granulocytes in actively induced Lewis rat EAE 232
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 230
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 229
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 227
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 227
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 225
Erythropoietin both protects from and reverses experimental diabetic neuropathy 224
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 223
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 221
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 220
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 219
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 218
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 215
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 212
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 211
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 211
Regression of diabetic complications by islet transplantation in the rat 209
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 209
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 208
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 207
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 203
Biodistrubution and toxicology of two PFCs intravenously injected in rats 203
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 202
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 201
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 197
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 196
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 193
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 192
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 191
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 188
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 187
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 184
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 184
The new analgesic CR4056 effectively abrogates neuropathic pain induced by Bortezomib in rats 183
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 183
Totale 26.536
Categoria #
all - tutte 92.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 0 0 0 0 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20254.492 283 607 355 210 350 119 203 169 477 616 416 687
2025/202610.671 1.143 684 911 923 1.173 747 1.887 614 1.010 1.008 571 0
Totale 30.427